[Form 4] KINGSTONE COMPANIES, INC. Insider Trading Activity

Rhea-AI Filing Summary

Kingstone Companies CEO and President Meryl S. Golden reported several common stock transactions. On December 31, 2025, she acquired 1,663 shares at $12.78 per share pursuant to the Company's Employee Stock Purchase Plan, bringing her direct holdings to 229,410 shares. On January 2, 2026, 7,735 shares were withheld from a vested stock grant at $16.83 per share to cover associated withholding taxes, leaving 221,675 directly held shares, which included 20,000 unvested restricted shares scheduled to vest on December 31, 2026.

On January 9, 2026, she received a 40,000-share restricted stock grant at $0, which is scheduled to vest on January 9, 2027. After this grant, she directly beneficially owned 261,675 shares, which included 60,000 unvested restricted shares scheduled to vest in tranches of 20,000 shares on December 31, 2026 and 40,000 shares on January 9, 2027. She also reported 25,000 shares held indirectly through an IRA.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Golden Meryl S.

(Last) (First) (Middle)

C/O KINGSTONE COMPANIES, INC.

120 WOOD ROAD

(Street)

KINGSTON NY 12401

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KINGSTONE COMPANIES, INC. [ KINS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, President

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/31/2025		A		1,663(1)	A	$12.78	229,410(2)	D
Common Stock	01/02/2026		F(3)		7,735	D	$16.83	221,675(4)	D
Common Stock	01/09/2026		A		40,000	A	$0(5)	261,675(6)	D
Common Stock								25,000	I	IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were acquired pursuant to the Company's Employee Stock Purchase Plan.

2. Includes 40,000 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 20,000 shares on January 2, 2026 and 20,000 shares on December 31, 2026.

3. Shares were withheld from vested stock grant to pay associated withholding taxes.

4. Includes 20,000 shares received pursuant to unvested restricted stock grant. Such shares vest on December 31, 2026.

5. Shares received pursuant to restricted stock grant. Such shares vest on January 9, 2027.

6. Includes 60,000 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 20,000 shares on December 31, 2026 and 40,000 shares on January 9, 2027.

	/s/ Meryl S. Golden	01/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.